Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,797 | 23,378 | 46,345 | 53,835 | 39,545 |
| Marketable Securities | 50,553 | 67,983 | 49,733 | 46,140 | 62,881 |
| Receivables | 68,440 | 16,845 | 14,299 | 14,664 | 17,474 |
| Other current assets | 0 | 597 | 2,646 | 2,086 | 2,038 |
| TOTAL | $161,067 | $116,480 | $119,307 | $124,294 | $133,541 |
| Non-Current Assets | |||||
| PPE Net | 7,418 | 7,788 | 8,142 | 8,717 | 9,068 |
| Other Non-Current Assets | 185,676 | 231,837 | 234,580 | 238,296 | 239,390 |
| TOTAL | $193,094 | $239,625 | $242,722 | $247,013 | $248,458 |
| Total Assets | $354,161 | $356,105 | $362,029 | $371,307 | $381,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,242 | 1,454 | 1,674 | 1,686 | 1,524 |
| Accrued Expenses | 10,006 | 9,221 | 7,733 | 6,951 | 9,343 |
| Other current liabilities | N/A | 6,490 | 6,490 | 6,490 | 6,490 |
| TOTAL | $32,085 | $23,435 | $22,946 | $21,662 | $24,767 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 146,531 | 147,016 | 145,394 | 144,777 | 144,237 |
| TOTAL | $146,531 | $147,016 | $145,394 | $144,777 | $144,237 |
| Total Liabilities | $178,616 | $170,451 | $168,340 | $166,439 | $169,004 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,471 | 49,174 | 48,922 | 48,633 | 48,165 |
| Retained earnings | -965,522 | -949,995 | -937,297 | -920,768 | -909,104 |
| Other shareholders' equity | 7 | 50 | -22 | -41 | -65 |
| TOTAL | $175,545 | $185,654 | $193,689 | $204,868 | $212,995 |
| Total Liabilities And Equity | $354,161 | $356,105 | $362,029 | $371,307 | $381,999 |